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Abstract 
Objectives: To understand how the emerging public health issue of chemsex relates to 
broader patterns of sexualised drug use (SDU) among men who have sex with men (MSM), 
which has been understudied.  
Methods: Potential participants were invited to take part in an anonymous cross-sectional 
online survey through Facebook advertising and community organisations’ social media posts 
(April-June 2018). Multivariable logistic regression was used to compare MSM who engaged 
in recent SDU (past 12 months) with those who did not, and those who engaged in chemsex 
(GHB/GBL, crystal methamphetamine, mephedrone, ketamine) with those who engaged in 
other SDU (e.g. poppers, cocaine, cannabis). 
Results: Of the 1,648 MSM included: 41% reported recent SDU; 15% of these (6% of total, 
n=99) reported chemsex. Factors associated with SDU were recent STI diagnosis (aOR=2.44, 
95%CI 1.58-3.76), sexual health clinic attendance (aOR=2.46, 95%CI 1.90-3.20), image and 
performance enhancing drug use (aOR=3.82, 95%CI 1.87-7.82), greater number of 
condomless anal male partners, lower satisfaction with life and greater sexual satisfaction. 
Predictors of chemsex compared to other SDU were: not being UK-born (aOR=2.02, 95%CI 
1.05-3.86), living in a densely populated area (aOR=2.69, 95%CI 1.26-5.74), low sexual self-
efficacy (aOR=4.52, 95%CI 2.18-9.40) and greater number of condomless anal male partners. 
Living with HIV, taking PrEP and experiencing or being unsure of experiencing sexual 
contact without consent were significantly associated with SDU and chemsex in bivariate 
analyses but not multivariable. 
Conclusion: Health and behavioural differences were observed between MSM engaging in 
chemsex, those engaging in SDU, and those engaging in neither. Whilst some MSM engaging 
in chemsex and SDU appeared content with these behaviours, the association with life 
3 
 
satisfaction and sexual self-efficacy indicates psychosocial support is needed for some. The 
association with sexual risk and sexual consent also indicates the importance of promoting 
harm reduction among this population (e.g. condoms, PrEP, drug knowledge). 
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Introduction 
The use of drugs among men who have sex with men (MSM) has historically been 
researched in the context of the HIV epidemic, due to the increased sexual risk as well as the 
increased risk of blood borne viruses associated with needle sharing when injecting drugs.[1, 
2] Sexualised drug use (SDU) refers to the use of drugs before or during sex to facilitate or 
enhance sexual activity, pleasure or intimacy. Estimates of the prevalence of SDU among 
MSM vary greatly depending on definition, measurement and recruitment methods used.[3] 
Chemsex (sometimes referred to as ‘party and play’) is a particular form of SDU among 
MSM where men engage in sex for long periods of time, with multiple sexual partners, with 
crystal methamphetamine, γ-hydroxybutyrate/γ-butyrolactone (GHB/GBL), mephedrone, 
cocaine and/or ketamine taken immediately before or during sex.[4] The rise of chemsex as a 
public health issue may be due to an increase in the number of people engaging in this 
behaviour and its associated sexual risk taking, which has been reported by sexual health 
services and men who engage in chemsex,[5, 6] both suggesting geospatial networking 
applications and online sites to meet sexual partners have enabled this increase. Quantitative 
research has also found a higher use of ‘barebacking’ (condomless sex) geospatial sexual 
networking applications among MSM engaging in chemsex.[7] 
The European MSM Internet Survey (EMIS) found that the three European cities with 
the highest prevalence of the use chemsex associated drugs were Brighton (16.3%), 
Manchester (15.5%) and London (13.2%).[8] Behaviourally, engaging in chemsex has been 
associated with more sexual partners, group sex, condomless anal intercourse, fisting, sharing 
sex toys, injecting drug use and higher alcohol consumption.[4, 7, 9] Whilst MSM reporting 
chemsex are more likely to be living with HIV, MSM who do not have HIV and report 
engaging in chemsex are more likely to have accessed post-exposure prophylaxis (PEP).[7, 
10] In Amsterdam, a higher proportion of MSM engaging in chemsex were taking pre-
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exposure prophylaxis (PrEP) compared to MSM not engaging in chemsex.[11] Among MSM 
living with HIV, illicit drug use has been associated with reduced antiretroviral therapy 
(ART) adherence and a detectable viral load, making transmission of HIV possible, and 
polydrug use was associated with increased condomless anal intercourse with a 
serodiscordant partner.[12, 13] When MSM have specified particular drug use, GHB, crystal 
methamphetamine, and non-chemsex related drugs (e.g. erectile dysfunction drugs, poppers) 
have been associated with condomless anal intercourse among MSM in England.[14] 
Reasons for engagement in chemsex that have been suggested in qualitative 
interviews are the stigma around HIV, internalised homophobia, and the intense sexual 
experience of chemsex.[15] However, quantitative research recruiting MSM through 
Facebook advertising did not find an association between internalised homophobia, 
experiences of discrimination, and sex under the influence of drugs in the UK.[16] Research 
to date into understanding SDU and its associated implications for sexual health has had a 
focus on health protection and health promotion, whereas the impact on mental health and 
psychological wellbeing has been somewhat neglected. During qualitative interviews with 
MSM engaging in chemsex in London, it was reported that chemsex was having an impact on 
some men’s personal relationships and professional conduct.[17] In Australia, being 
dependent on methamphetamine was associated with depression and anxiety compared to 
non-dependant users, but this was not measured in a sexual context.[18] In Dublin, a quarter 
of MSM attending a sexual health clinic reported that chemsex was having a negative impact 
on their lives, 17% reported losing consciousness whilst engaging in chemsex, and 6% 
reported their partners had lost consciousness,[19] and MSM have reported in qualitative 
interviews feeling uncomfortable in these situations, due to issues regarding a person’s ability 
to consent to sex.[17]  
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Research into chemsex and other forms of SDU among MSM in the UK to date has 
mostly been situated in urban areas and/or sexual health clinics.[3] To inform public health 
responses, this study examines both chemsex and SDU across the UK, comparing differences 
in sexual and psychosocial characteristics between MSM who do not engage in any forms of 
SDU, those who engage in SDU, and those who engage in chemsex. 
Method 
Design 
This analysis uses data from a sample of MSM recruited via a national cross-sectional 
online questionnaire aimed at LGBT people aged 18 or over in the UK. Ethical approval for 
this study was obtained by the Liverpool John Moores University Research Ethics Committee 
(approval reference: 18/PHI/011). A convenience sample was obtained using sponsored 
Facebook advertising and promotion on social media via relevant LGBT organisations. Four 
LGBT organisations across the UK promoted the survey on their social media accounts 
(COAST, London Friend, the Gay Men’s Health Collective and The National LGB&T 
Partnership). A sample size calculation using the Public Health England estimate that 2.5% of 
the population in England are lesbian, gay, or bisexual,[20] a margin of error of 5% and 95% 
confidence interval, indicated a minimum target sample size for MSM was 384. 
Participants 
Four sponsored adverts were run on Facebook for 6 weeks between April-June 2018, 
targeting MSM, women who have sex with women (WSW), trans people, or LGBT people 
generally. Facebook users were shown the sponsered advert for the “Sex and Lifestyles 
survey” if they engaged with one or more MSM or LGBT topics on Facebook. Participants 
were invited to take part in the survey if they had ever had a sexual partner of the same 
gender and/or they identified as trans. Participants would then be directed to the online 
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survey and asked two screening questions, ensuring that participants were aged eighteen or 
over and currently lived in the UK. To aid recruitment participants had the option to enter a 
prize draw for a £50 or one of two £25 Amazon vouchers. 
Measures 
The questionnaire was divided into three areas: demographics, sexual health and drug 
use, and psycholgical wellbeing. MSM participants were those who identified as male and 
who gave their sexual orientation as gay or bisexual, or who stated they had sex with men. 
Sexual health questions were adapted from research on similar topics.[21] Aligned with 
previous research, questions about drug use and SDU were asked with regards to specific 
drugs.[22] Participants were first asked if they had taken any of the 14 listed drugs (including 
alcohol) in the past 12 months. SDU was grouped as participants who had stated they had 
been under the influence of cannabis during sex in the past 12 months, or stated having taken 
amphetamine, cocaine, crack cocaine, ecstasy, heroin, GHB/GBL, ketamine, mephedrone, 
methamphetamine, Viagra or other erectile dysfunction drug, poppers, or another unspecified 
drug just before or during sex in the past 12 months. The chemsex group was defined as 
having taken GHB/GBL, ketamine, mephedrone and/or methamphetamine just before or 
during sex.  
Sexual satisfaction was measured using an adapted version of the New Sexual 
Satisfaction Scale,[23] and sexual self-efficacy (participants’ confidence in practicing safer 
sex consistently) was measured using a previously validated tool for use with MSM.[24] 
Questions regarding motivations for engaging in SDU and sex under the influence of alcohol 
were adapted from motivations and attitudes towards chemsex questions.[9] Psychological 
wellbeing was measured using a variety of previously validated scales: the Internalised 
Homophobia scale;[25] Objectified Body Consciousness scale to measure body image 
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satisfaction;[26] a 3-item loneliness scale;[27] the Satisfaction With Life Scale [SWLS; 28] 
and the Kessler Psychological Distress Scale.[29]  
 
Analysis  
 All analyses were conducted using SPSS 25. Forward stepwise multivariable logistic 
regression analyses were used to explore factors associated with engaging in SDU compared 
to not engaging in SDU, and factors associated with engaging in chemsex as opposed to SDU 
(entry p<0.05, removal p>0.10). Factors significant at the univariate level (p<0.05) were 
included in the multivariable model. Descriptive chi-square analyses were used to compare 
motivations for and effects of engaging in, chemsex, other types of SDU, and sex under the 
influence of alcohol. 
Results 
 Of the 4,690 surveys started, 96 participants did not meet the eligibility criteria, and 
1,014 did not complete the survey sufficiently to be included in analyses (completion rate of 
78%). Overall, the median time taken to complete the survey was 12 minutes. Of the 3,676 
participants included, 1,663 were identified as MSM, and 1,648 of these MSM (99%) had 
completed the drug use and sex questions to be included in the analysis. MSM who 
completed the survey were more likely to be university educated (53% vs. 61%, p<0.05), but 
did not differ on any other demographic variables where data were available. One MSM 
identified as heterosexual and was therefore not included in the analysis. The majority of 
MSM identified as gay/homosexual (86%), were of white ethnicity (95%), with a mean age 
of 30.7 (SD =  10.4, range 18-76), and 43% stated they were single/not in a relationship. Half 
of participants had attended a GUM clinic in the past 12 months, 4% were living with HIV, 
6% were taking PrEP, and 5% reported having had sexual contact without consent in the past 
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12 months. There was no statistical difference between London (45%, n=121/264) and 
outside of London (39%, n=545/1375) for SDU, and no statistical difference between MSM 
reporting recent chemsex between London (11%, n=30/263) and other densely populated 
areas (9%, n=25/287). 
 SDU was reported by 41% of MSM: 28% of MSM had taken amyl nitrates (poppers) 
immediately before/during sex; 13% had been under the influence of cannabis during sex; 
12% had taken viagra before or during sex, and 10% had taken cocaine before or during sex. 
Less prevalent drugs taken before or during sex were ecstacy (4%), GHB/GBL (3%), 
mephedrone (3%), methamphetamine (2%), ketamine (2%), amphetamines (1%), and other 
drug not specified (1%). GHB/GBL, ketamine, methamphetamine and mephedrone were 
grouped as chemsex drugs and 99 (6%) MSM had engaged in chemsex drug use just before 
or during sex.  
Table 1 displays the multivariable analysis describing sexual and psychosocial 
characteristics of MSM who had engaged in any SDU in the past 12 months, compared to 
MSM who did not report any SDU. Due to the strong association between the number of 
male anal intercourse partners and number of condomless male anal intercourse partners in 
the past 12 months, only the latter was included in the multivariable analysis, due to greater 
sexual risk. Factors associated with SDU in the multivariable analysis were being aged 35 
years and over, having a recent STI diagnosis, recently attending a GUM clinic, having a 
greater number of condomless male anal intercourse partners, recent image and performance 
enhancing drug use, having a lower satisfaction with life and greater sexual satisfaction.  
This analysis was then repeated for factors associated with chemsex compared to 
other SDU in the past 12 months (Table 2). Factors associated with chemsex in the 
multivariable analysis were being a person of colour, living in a more densely populated area, 
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having 6 or more condomless male anal intercourse partners and having low sexual self-
efficacy. 
Three quarters (74%) of the sample had engaged in any type of SDU or sex under the 
influence of alcohol. Figure 1 compares motivations for and effects of engaging in chemsex, 
other SDU and sex under the influence of alcohol in the past 12 months. Chi-square analyses 
showed MSM engaging in chemsex were more likely to do so because it gave them an 
intense sexual experience, allowed them to have sex for longer, were more likely to have sex 
without a condom and do things they would not do sober, compared to other SDU and those 
having sex under the influence of alcohol. MSM engaging in chemsex were also more likely 
to report engagement was having a negative impact on their life, and were doing so because 
of pressure from friends. 
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Table 1. Univariate and multivariable analyses for factors associated sexualised drug use in the past 12 months. 
      
Univariate Adjusted model 
 
MSM not engaged in sexualised drug use (n=978) MSM engaged in sexualised drug use (n=670) OR (95% CI) aOR (95% CI) 
 
n or mean % or SD n or mean % or SD Row %     
Sexuality      
    
Homosexual 824 84% 587 88% 42% ref. 
 
Bisexual 108 11% 44 7% 29% 0.57 (0.40, 0.83)** 
 
Queer 24 2% 26 4% 52% 1.52 (0.86, 2.68) 
 
Age group 
       
18-24 359 37% 174 26% 33% ref. ref. 
25-34 403 41% 240 36% 37% 1.23 (0.97, 1.56) 1.08 (0.81, 1.44) 
35-49 171 17% 186 28% 52% 2.24 (1.70, 2.96)*** 2.51 (1.81, 3.50)*** 
>=50 44 4% 68 10% 61% 3.19 (2.10, 4.85)*** 4.00 (2.43, 6.59)*** 
Ethnicity 
       
White 934 96% 637 95% 41% ref. 
 
Person of colour 42 4% 32 5% 43% 1.12 (0.70, 1.79) 
 
Country of Birth 
       
UK 855 87% 577 86% 40% ref. 
 
Not UK 106 11% 76 11% 42% 1.06 (0.78, 1.45) 
 
Education 
       
University or higher 578 59% 401 60% 41% ref. 
 
Qualifications at 18 290 30% 176 26% 38% 0.88 (0.70, 1.10) 
 
Qualifications at 16 or lower 87 9% 75 11% 46% 1.24 (0.89, 1.74) 
 
Work Status 
       
Full time 615 63% 426 64% 41% ref. 
 
Part time 69 7% 44 7% 39% 0.92 (0.62, 1.37) 
 
Student 185 19% 79 12% 30% 0.62 (0.46, 0.83)** 
 
Unemployed 35 4% 24 4% 41% 0.99 (0.58, 1.69) 
 
Other (sick leave, retired, carer) 70 7% 91 14% 57% 1.88 (1.34, 2.62)*** 
 
Relationship status 
       
Living with partner 355 36% 232 35% 40% ref. 
 
Relationship not living with partner 197 20% 120 18% 38% 0.93 (0.70, 1.23) 
 
Relationship with multiple 17 2% 18 3% 51% 1.62 (0.82, 3.21) 
 
Single 408 42% 299 45% 42% 1.12 (0.90, 1.40) 
 
Population density per hectare 
      
<5 225 23% 136 20% 38% ref. 
 
5 - 20  219 22% 127 19% 37% 0.96 (0.71, 1.30) 
 
20 - 41  233 24% 166 25% 42% 1.18 (0.88, 1.58) 
 
>41  287 29% 236 35% 45% 1.36 (1.04, 1.79)* 
 
Internalized homophobia 
      
Low 616 63% 444 66% 42% ref. 
 
High 354 36% 213 32% 38% 0.84 (0.68, 1.03) 
 
Discrimination sexuality 
       
None 534 55% 340 51% 39% ref. 
 
Any setting 414 42% 297 44% 42% 1.13 (0.92, 1.38) 
 
Perceived health 
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Fair/good/very good 877 90% 580 87% 40% ref. 
 
Very poor/poor 101 10% 90 13% 47% 1.35 (1.00, 1.82) 
 
Psychological distress 
       
Normal 206 21% 153 23% 43% ref. 
 
Moderate 220 22% 154 23% 41% 0.94 (0.70, 1.26) 
 
High 267 27% 152 23% 36% 0.77 (0.57, 1.02) 
 
Very high 275 28% 203 30% 42% 0.99 (0.75, 1.31) 
 
Diagnosed STI in the past 12 months 
     
None 903 92% 511 76% 36% ref. ref. 
STI diagnosis 42 4% 135 20% 76% 5.68 (3.95, 8.17)*** 2.44 (1.58, 3.76)*** 
Not stated 33 3% 24 4% 42% 1.29 (0.75, 2.20) 1.45 (0.77, 2.71) 
Attended GUM in the past 12 months 
     
No 594 61% 199 30% 25% ref. ref. 
Yes 368 38% 457 68% 55% 3.71 (3.00, 4.58)*** 2.46 (1.90, 3.20)*** 
Not sure 9 1% 9 1% 50% 2.99 (1.17, 7.62)* 3.61 (1.15, 11.34)* 
No. of men anal intercourse in the past 12 months 
    
0-1 622 63% 182 27% 23% ref. 
 
2-5 261 27% 190 28% 42% 2.49 (1.94, 3.19)*** 
 
6-10 52 5% 126 19% 71% 8.28 (5.76, 11.90)*** 
 
>10 40 4% 171 26% 81% 14.61 (9.97, 21.40)*** 
 
No. of men without condom anal intercourse in the past 12 months 
  
0-1 811 83% 362 54% 31% ref. ref. 
2-5 137 14% 170 25% 55% 2.79 (2.16, 3.60)*** 1.77 (1.31, 2.40)*** 
6-10 17 2% 63 9% 79% 8.33 (4.80, 14.43)*** 4.31 (2.38, 7.80)*** 
>10 7 1% 74 11% 91% 23.75 (10.83, 52.06)*** 8.42 (3.67, 19.29)*** 
Sexual contact without consent in the past 12 months 
    
No 925 95% 595 89% 39% ref. 
 
Yes 37 4% 41 6% 53% 1.72 (1.09, 2.72)*  
Unsure 12 1% 24 4% 67% 3.11 (1.54, 6.26)**  
HIV status 
       
Negative 807 83% 496 74% 38% ref.  
Negative, on PrEP 28 3% 71 11% 72% 4.12 (2.63, 6.48)***  
Positive 19 2% 55 8% 74% 4.71 (2.76, 8.03)***  
Don't know 124 13% 48 7% 28% 0.63 (0.44, 0.90)*  
Sexual self-efficacy 
       
High  934 96% 615 92% 40% ref.  
Low 34 3% 44 7% 56% 2.03 (1.28, 3.22)**  
Taken image or performance enhancing drugs in the past 12 months?       
No 959 98% 629 94% 40% ref. ref. 
Yes 19 2% 36 5% 65% 2.89 (1.64, 5.08)*** 3.82 (1.87, 7.82)*** 
Body satisfaction 42.0 11.8 41.3 12.7 
 
1.00 (0.99, 1.00) 
 
Loneliness score 5.5 1.8 5.5 1.8 
 
1.01 (0.96, 1.07) 
 
Satisfaction with life  20.6 7.1 19.6 7.6 
 
0.98 (0.97, 1.00)** 0.97 (0.95, 0.99)*** 
Sexual satisfaction 40.6 9.2 42.5 8.7 
 
1.02 (1.01, 1.04)*** 1.03 (1.01, 1.04)*** 
*p<0.05 
**p<0.01 
***p<0.001  
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Table 2. Univariate and multivariable analyses for factors associated with engaging in chemsex in the past 12 months compated to other sexualised drug use. 
      
Univariate Adjusted model 
 
MSM engaged in other 
sexualised drug use 
(n=570) 
MSM engaged in chemsex 
(n=99) OR (95% CI) aOR (95% CI) 
 
n or mean 
% or 
SD 
n or 
mean 
% or 
SD 
Row 
% 
    
Sexuality 
         
Homosexual 497 87% 90 91% 15% ref. 
 
Bisexual 40 7% 4 4% 9% 0.55 (0.19, 1.58) 
 
Queer 23 4% 3 3% 12% 0.72 (0.21, 2.45) 
 
Age group 
       
18-24 154 27% 20 20% 11% ref. 
 
25-34 198 35% 42 42% 18% 1.63 (0.92, 2.90) 
 
35-49 152 27% 34 34% 18% 1.72 (0.95, 3.13) 
 
>=50 65 11% 3 3% 4% 0.36 (0.10, 1.24) 
 
Ethnicity 
       
White 548 96% 89 90% 14% ref. 
 
Person of colour 22 4% 10 10% 31% 2.80 (1.28, 6.11)* 
 
Country of Birth 
       
UK 497 87% 80 81% 14% ref. ref. 
Not UK 57 10% 19 19% 25% 2.07 (1.17, 3.66)* 2.02 (1.05, 3.86)* 
Education 
       
University or higher 337 59% 64 65% 16% ref. 
 
Qualifications at 18 154 27% 22 22% 13% 0.75 (0.45, 1.27) 
 
Qualifications at 16 or lower 63 11% 12 11% 16% 1.00 (0.51, 1.97) 
 
Work Status 
       
Full time 356 62% 70 71% 16% ref. 
 
Part time 38 7% 6 6% 14% 0.80 (0.33, 1.97) 
 
Student 73 13% 6 6% 8% 0.42 (0.18, 1.00) 
 
Unemployed 20 4% 4 4% 17% 1.02 (0.34, 3.07) 
 
Other (sick leave, retired, carer) 78 14% 13 13% 14% 0.85 (0.45, 1.61) 
 
Relationship status 
       
Living with partner 202 35% 31 31% 13% ref. 
 
Relationship not living with partner 105 18% 15 15% 13% 0.93 (0.48, 1.80) 
 
Relationship with multiple 14 2% 4 4% 22% 1.85 (0.57, 6.00) 
 
Single 250 44% 49 49% 16% 1.27 (0.78, 2.07) 
 
Population density per hectre 
      
<5 126 22% 10 10% 7% ref. ref. 
5 - 20  120 21% 7 7% 6% 0.74 (0.27, 1.99) 0.59 (0.21, 1.69) 
20 - 41  139 24% 27 27% 16% 2.45 (1.14, 5.26)* 1.86 (0.82, 4.21) 
>41  181 32% 55 56% 23% 3.83 (1.88, 7.80)*** 2.69 (1.26, 5.74)* 
Internalized homophobia 
       
Low 373 65% 71 72% 16% ref. 
 
High 189 33% 24 24% 11% 0.67 (0.41, 1.09) 
 
Discrimination sexuality 
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None 294 52% 46 46% 14% ref. 
 
Any setting 248 44% 49 49% 16% 1.26 (0.82, 1.95) 
 
Perceived health 
       
Fair/good/very good 499 88% 81 82% 14% ref. 
 
Very poor/poor 72 13% 18 18% 20% 1.54 (0.87, 2.72) 
 
Psychological distress 
       
Normal 130 23% 23 23% 15% ref. 
 
Moderate 131 23% 23 23% 15% 0.99 (0.53, 1.86) 
 
High 133 23% 19 19% 13% 0.81 (0.42, 1.55) 
 
Very high 172 30% 31 31% 15% 1.02 (0.57, 1.83) 
 
Diagnosed STI 
       
None 448 79% 63 64% 12% ref.  
STI diagnosis 99 17% 36 36% 27% 2.59 (1.63, 4.12)***  
Not stated 24 4% 0 0% 0% -  
Attended GUM 
      
 
No 186 33% 13 13% 7% ref.  
Yes 374 65% 83 84% 18% 3.18 (1.72, 5.85)***  
Not sure 7 1% 2 2% 22% 4.09 (0.77, 21.70)  
No. of men anal intercourse in the past 12 months 
    
 
0-1 175 31% 7 7% 4% ref.   
2-5 171 30% 19 19% 10% 2.78 (1.14, 6.78)*   
6-10 105 18% 21 21% 17% 5.00 (2.06, 12.16)***   
>10 119 21% 52 53% 30% 10.92 (4.80, 24.87)  
No. of men without condom anal intercourse in the past 12 months 
  
 
0-1 338 59% 23 23% 6% ref. ref. 
2-5 143 25% 27 27% 16% 2.78 (1.54, 5.00)** 2.15 (0.85, 5.41) 
6-10 49 9% 14 14% 22% 4.20 (2.03, 8.70)*** 4.02 (1.60, 10.12)** 
>10 39 7% 35 35% 47% 13.19 (7.08, 24.56)*** 7.86 (3.38, 18.30)*** 
Sexual contact without consent in the past 12 months 
    
No 512 90% 83 84% 14% ref.  
Yes 34 6% 7 7% 17% 1.27 (0.55, 2.96)  
Unsure 15 3% 9 9% 38% 3.70 (1.57, 8.73)**  
HIV status 
       
Negative 443 78% 53 54% 11% ref.  
Negative, on PrEP 50 9% 21 21% 30% 3.51 (1.96, 6.29)***  
Positive 35 6% 20 20% 36% 4.78 (2.57, 8.87)***  
Don't know 43 8% 5 5% 10% 0.97 (0.37, 2.56)  
Sexual self-efficacy 
       
High  538 94% 77 78% 13% ref. ref. 
Low 25 4% 19 19% 43% 5.31 (2.79, 10.10)*** 4.52 (2.18, 9.40)*** 
Taken image or performance enhancing drugs in the past 12 
months?       
No 538 94% 91 92% 14% ref.  
Yes 30 5% 6 6% 17% 1.18 (0.48, 2.92)  
Body satisfaction 41.0 12.6 42.9 13.1 
 
1.01 (1.00, 1.03) 
 
Loneliness score 5.5 1.8 5.5 1.7 
 
1.00 (0.89, 1.13) 
 
Satisfaction with life  19.7 7.7 19 7.1 
 
0.99 (0.96, 1.02) 
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Sexual satisfaction 42.3 8.9 43.6 7.5 
 
1.02 (0.99, 1.04) 
 
*p<0.05 
**p<0.01 
***p<0.001 
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Figure 1. Comparing reasons for engagement and effect of chemsex, other sexualised drug use, and sex under the influence of alcohol. 
*p<0.05 
**p<0.01 
***p<0.001
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Discussion 
This study investigated the sexual and psychosocial characteristics associated with 
engaging in SDU and chemsex among an internet sample of UK MSM, and provides novel 
insights into how the relationships with wellbeing and self-efficacy vary between these 
groups. Engaging in SDU was associated with more condomless anal intercourse with male 
partners than those who did not engage in SDU, and engaging in chemsex was associated 
with more condomless anal intercourse than other types of SDU. Engaging in SDU was also 
associated with the use of image and performance enhancing drugs in the past 12 months, but 
this difference was not observed when comparing those who engage in chemsex with 
engaging in other SDU.  
This cross-sectional study obtained a large sample of MSM from across the UK to 
investigate chemsex and SDU. Previous research into SDU and chemsex has mostly been 
based in densely populated areas, usually recruiting from sexual health clinics.[3] It was 
observed that broad SDU did not differ by population density, but chemsex was reported 
more often in densly populated areas, highlighting geographic differences in the type of SDU 
MSM engage in. This is of significance to sexual health clinics nationally, as both SDU and 
chemsex were associated with sexual risks, and issues around sexual consent.  
Whilst using Facebook as a method of recruitment enabled the large sample size, the 
sample was slightly young, and the sample is biased to participants with social media 
accounts. Due to the large proportion of MSM identifying as white, the results may not be 
representative of MSM of colour, which has been noted as an issue in other UK-based LGBT 
research [30]. A possible way for future research to overcome this is to use organisations 
specific to LGBT people of colour. Being born outside the UK was a predictor of engaging in 
chemsex, therefore future research in this area should aim to recruit MSM of colour, as well 
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as those being born outside of the UK to investigate the possible intersectionality between 
sexuality, ethnicity and country of birth.  
Similar to previous research, MSM engaging in SDU were more likely to have 
engaged in condomless anal intercourse.[4, 7, 9, 14] MSM engaging in SDU were also more 
likely to have attended a GUM clinic in the past 12 months and received an STI diagnosis.[7, 
10, 11] However, when comparing MSM engaging in chemsex with MSM engaging in other 
types of SDU, this difference did not hold at the multivariable level, possibly due to the 
overlap with number of condomless anal intercourse partners. MSM engaging in chemsex 
were more likely to be taking PrEP compared to MSM engaging in other SDU, which is 
similar to findings in Amsterdam,[11] but possibly due to the overlap between taking PrEP 
and number of condomless anal intercourse partners, this was not significant at the 
multivariable level.  
Although the stigma of living with HIV has been suggested as motivation for 
engaging in chemsex,[15] living with HIV was not significantly associated with SDU or 
chemsex once other factors were controlled for, similar to other UK research.[7] However, 
this could be due to an overlap with confounding variables, and due to the higher proportion 
of MSM living with HIV engaging in chemsex, support services for MSM living with HIV 
need to be aware of the possible impacts of this behaviour. A previous qualitative study had 
suggested internalised homophobia and experiences of discrimination as possible reasons for 
engaging in chemsex,[15] but this was not observed here.  
Engaging in SDU was associated with lower life satisfaction, but there was no 
significant difference in life satisfaction between those engaging in chemsex, and those 
engaging in other types of SDU. Previous research has mostly focused on the physical health 
effects of SDU, and neglected possible psychological associations. Additionally, MSM 
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engaging in chemsex were more likely to report their SDU having a negative impact on their 
life. The proportion of MSM engaging in chemsex reporting a negative impact is similar to 
research in Ireland;[9] however this is the first study to investigate how this differs between 
chemsex, other forms of SDU and sex under the influence of alcohol. Those engaging in 
SDU reported greater sexual satisfaction, compared to those not engaging in SDU, but no 
difference was observed between engaging in chemsex and in other SDU. Although, MSM 
engaging in chemsex were more likely to report doing so because of the intense sexual 
experience and being able to have sex for longer. This suggests the perceived benefits, risks, 
and possible negative impacts from engaging in SDU and chemsex are complex.  
In the bivariate analyses, MSM engaging in SDU were more likely to report having 
experienced or being unsure of having sexual contact without consent in the past 12 months, 
and when comparing chemsex with other SDU, MSM engaging in chemsex were more likely 
to report being unsure of sexual contact without consent. These associations did not remain in 
the multivariable analyses, possibly due to small numbers reporting recent sexual contact 
without consent, and this being associated with other factors. Despite this, these findings still 
highlight a possible issue of how consent is affected during SDU and chemsex. 
These results highlighted how SDU and chemsex can impact the health and wellbeing 
of MSM, and differences in motivations for engaging in these behaviours. Whilst it is 
encouraging to find a higher percentage of MSM engaging in SDU and chemsex were more 
likely to take PrEP, further research is needed to understand possible interactions between 
PrEP adherence, drug interactions, and possible barriers for MSM engaging in SDU and 
chemsex taking PrEP, due to the elevated sexual risk associated with these behaviours. 
Furthermore, these results should promote awareness among clinicians around the issue of 
consent and SDU, and ensure referral pathways and patient safeguarding strategies are in 
place.  
20 
 
In conclusion, this research highlights a complex interaction between motivations, 
perceived benefits and negative impacts for engaging in SDU and chemsex. Despite the vast 
majority of participants stating they were content and in control of their sex life, engaging in 
SDU was associated with a lower life satisfaction and engaging in chemsex was associated 
with lower sexual self-efficacy. Due to the associated sexual risk taking, issues around sexual 
consent and possible harms from drug use, it is important to promote harm reduction among 
this population (e.g. condoms, PrEP, drug knowledge and safer drug use), whilst having 
support services in place for anyone wanting to stop, or who are experiencing negative effects 
of engaging in these behaviours.  
Word count: 2,997 
Key messages 
 Motivations for and associated benefits and risks of engagement in sexualised drug 
use and chemsex among MSM are complex. 
 Sexual assault was associated with sexualised drug use and chemsex, therefore greater 
awareness of this risk should be promoted among MSM and support services.  
 Harm reduction should be promoted among MSM engaging in sexualised drug use 
and chemsex as well as referral pathways for those experiencing negative effects.  
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